Stocks and Investing
Stocks and Investing
Fri, June 28, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joon Lee Maintained (VRNA) at Strong Buy with Increased Target to $38 on, Jun 28th, 2024
Joon Lee of Truist Securities, Maintained "Verona Pharma plc" (VRNA) at Strong Buy with Increased Target from $32 to $38 on, Jun 28th, 2024.
Joon has made no other calls on VRNA in the last 4 months.
There are 4 other peers that have a rating on VRNA. Out of the 4 peers that are also analyzing VRNA, 0 agree with Joon's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Joon
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy and Held Target at $35 on, Thursday, June 27th, 2024
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $36 on, Thursday, June 27th, 2024
- Yasmeen Rahimi of "Piper Sandler" Maintained at Buy with Increased Target to $36 on, Tuesday, April 16th, 2024
- Liana Moussatos of "Wedbush" Reiterated at Buy and Held Target at $33 on, Friday, March 1st, 2024
Contributing Sources